Matches in DBpedia 2016-04 for { ?s ?p "José Baselga, MD, PhD., is a Spanish board-certified medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Baselga maintains a clinical practice where he cares for women with all stages of breast cancer, and serves as the Physician-in-Chief at Memorial Sloan Kettering Cancer Center.Baselga oversees the clinical component of Memorial Sloan Kettering Cancer Center his responsibilities include the management of patient care delivery in Memorial Hospital as well as at Memorial Sloan Kettering’s clinics and regional sites. Baselga is also focused on implementing the clinical strategic planning and in charge of enhancing Memorial Sloan Kettering’s clinical and translational research. Before returning to Memorial Sloan Kettering, Baselga led the Vall d´Hebron Hospital in Barcelona, Spain, a comprehensive cancer center with a large multidisciplinary research program including the largest phase I program for new cancer therapies in Europe. Thereafter, Baselga moved to the Massachusetts General Hospital in Boston to become Chief of the Hematology/Oncology Division and Associate Director of the Massachusetts General Cancer Center. At Massachusetts General, Baselga focused on implementation of strategic plans promoting growth of patient volume and an unparalleled expansion of the phase I program including the creation of a new state of the art facility and was named President-Elect of the American Association for Cancer Research for 2014–2015.Memorial Sloan Kettering Cancer Center.In 2014 Baselga was inducted into the Spanish Royal Academy of Pharmacy and the Institute of Medicine of the National Academy of Sciences.He has published over 350 peer-reviewed articles.Dr Baselga received his MD degree from the Autonomous University of Barcelona in 1982. He completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York and subsequently stayed on as a faculty member of the Breast Medicine Service at Memorial Sloan-Kettering. From 1996 to 2010 he was the Chairman of the Medical Oncology Service and Founding Director of the recently established Vall d’Hebron Institute of Oncology (VHIO) at the Vall d'Hebron University Hospital in Barcelona. From 2010 to 2012, he was the chief of the Division of Hematology/Oncology and associate director of the MGH Cancer Center in Massachusetts."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Jose_Baselga abstract "José Baselga, MD, PhD., is a Spanish board-certified medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Baselga maintains a clinical practice where he cares for women with all stages of breast cancer, and serves as the Physician-in-Chief at Memorial Sloan Kettering Cancer Center.Baselga oversees the clinical component of Memorial Sloan Kettering Cancer Center his responsibilities include the management of patient care delivery in Memorial Hospital as well as at Memorial Sloan Kettering’s clinics and regional sites. Baselga is also focused on implementing the clinical strategic planning and in charge of enhancing Memorial Sloan Kettering’s clinical and translational research. Before returning to Memorial Sloan Kettering, Baselga led the Vall d´Hebron Hospital in Barcelona, Spain, a comprehensive cancer center with a large multidisciplinary research program including the largest phase I program for new cancer therapies in Europe. Thereafter, Baselga moved to the Massachusetts General Hospital in Boston to become Chief of the Hematology/Oncology Division and Associate Director of the Massachusetts General Cancer Center. At Massachusetts General, Baselga focused on implementation of strategic plans promoting growth of patient volume and an unparalleled expansion of the phase I program including the creation of a new state of the art facility and was named President-Elect of the American Association for Cancer Research for 2014–2015.Memorial Sloan Kettering Cancer Center.In 2014 Baselga was inducted into the Spanish Royal Academy of Pharmacy and the Institute of Medicine of the National Academy of Sciences.He has published over 350 peer-reviewed articles.Dr Baselga received his MD degree from the Autonomous University of Barcelona in 1982. He completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York and subsequently stayed on as a faculty member of the Breast Medicine Service at Memorial Sloan-Kettering. From 1996 to 2010 he was the Chairman of the Medical Oncology Service and Founding Director of the recently established Vall d’Hebron Institute of Oncology (VHIO) at the Vall d'Hebron University Hospital in Barcelona. From 2010 to 2012, he was the chief of the Division of Hematology/Oncology and associate director of the MGH Cancer Center in Massachusetts.".
- Q6279267 abstract "José Baselga, MD, PhD., is a Spanish board-certified medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Baselga maintains a clinical practice where he cares for women with all stages of breast cancer, and serves as the Physician-in-Chief at Memorial Sloan Kettering Cancer Center.Baselga oversees the clinical component of Memorial Sloan Kettering Cancer Center his responsibilities include the management of patient care delivery in Memorial Hospital as well as at Memorial Sloan Kettering’s clinics and regional sites. Baselga is also focused on implementing the clinical strategic planning and in charge of enhancing Memorial Sloan Kettering’s clinical and translational research. Before returning to Memorial Sloan Kettering, Baselga led the Vall d´Hebron Hospital in Barcelona, Spain, a comprehensive cancer center with a large multidisciplinary research program including the largest phase I program for new cancer therapies in Europe. Thereafter, Baselga moved to the Massachusetts General Hospital in Boston to become Chief of the Hematology/Oncology Division and Associate Director of the Massachusetts General Cancer Center. At Massachusetts General, Baselga focused on implementation of strategic plans promoting growth of patient volume and an unparalleled expansion of the phase I program including the creation of a new state of the art facility and was named President-Elect of the American Association for Cancer Research for 2014–2015.Memorial Sloan Kettering Cancer Center.In 2014 Baselga was inducted into the Spanish Royal Academy of Pharmacy and the Institute of Medicine of the National Academy of Sciences.He has published over 350 peer-reviewed articles.Dr Baselga received his MD degree from the Autonomous University of Barcelona in 1982. He completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York and subsequently stayed on as a faculty member of the Breast Medicine Service at Memorial Sloan-Kettering. From 1996 to 2010 he was the Chairman of the Medical Oncology Service and Founding Director of the recently established Vall d’Hebron Institute of Oncology (VHIO) at the Vall d'Hebron University Hospital in Barcelona. From 2010 to 2012, he was the chief of the Division of Hematology/Oncology and associate director of the MGH Cancer Center in Massachusetts.".